Table 1 Logistic analysis of the correlation between OTUD3 mRNA expression and clinical characteristics in breast cancer
Characteristics | Total (n) | OR (95% CI) | p value |
|---|---|---|---|
Age (> 60 vs. <= 60) | 1087 | 0.967 (0.762–1.229) | 0.786 |
Race (Black or African American&White vs. Asian) | 997 | 1.558 (0.912–2.663) | 0.105 |
Menopause status (Pre&Peri vs. Post) | 976 | 0.944 (0.713–1.250) | 0.690 |
Pathologic T stage (T2&T3&T4 vs. T1) | 1084 | 0.762 (0.580–1.002) | 0.052 |
Pathologic N stage (N1&N2&N3 vs. N0) | 1068 | 0.848 (0.667–1.078) | 0.178 |
Pathologic M stage (M1 vs. M0) | 925 | 0.802 (0.329–1.954) | 0.627 |
Pathologic stage (Stage III&Stage IV vs. Stage I&Stage II) | 1063 | 0.857 (0.648–1.133) | 0.278 |
Histological type (Infiltrating Ductal Carcinoma vs. Infiltrating Lobular Carcinoma&Infiltrating Carcinoma NOS&Medullary Carcinoma&Mixed Histology &Mucinous Carcinoma) | 1034 | 0.733 (0.552–0.973) | 0.031* |
ER status (Positive vs. Negative&Indeterminate) | 1039 | 1.494 (1.117–1.998) | 0.007* |
PR status (Positive vs. Negative&Indeterminate) | 1038 | 1.360 (1.049–1.763) | 0.020* |
HER2 status (Positive vs. Negative&Indeterminate) | 729 | 0.549 (0.383–0.788) | 0.001* |
PAM50 (Normal&LumA&LumB&Her2 vs. Basal) | 1087 | 1.272 (0.932–1.736) | 0.130 |
Anatomic neoplasm subdivisions (Left vs. Right) | 1087 | 1.105 (0.871–1.401) | 0.413 |